Estados Unidos · Bolsa y Finanzas · Washington Post Business

Health Brief: Eli Lilly takes on retatrutide copycats

Publicado por Washington Post Business · Estados Unidos hace 15 h

Eli Lilly is suing five more companies accused of selling illicit copies of its experimental weight loss drug retatrutide as CEO Dave Ricks presses regulators to do more Insurers…

Leer el artículo completo en Washington Post Business Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.washingtonpost.com)

Health Brief: Eli Lilly takes on retatrutide copycats

También te puede interesar

XRP Ledger patched decade-old bug that could create billions of dollars in XRP from nothing

Trump's AI rebrand is catching on with Elon Musk and Marc Benioff

Elon Musk intensifies attack on Ambani over Starlink India launch delay

Trump's diesel agreement with Putin accused of contradicting Russia sanctions law

Trump turns to Russia in bid to lower diesel prices, but analysts see minimal impact

Big Controversy Upends a Contest About Microscopic Videos

Health Brief: Eli Lilly takes on retatrutide copycats

Compartir

También te puede interesar

XRP Ledger patched decade-old bug that could create billions of dollars in XRP from nothing

Trump's AI rebrand is catching on with Elon Musk and Marc Benioff

Elon Musk intensifies attack on Ambani over Starlink India launch delay

Trump's diesel agreement with Putin accused of contradicting Russia sanctions law

Trump turns to Russia in bid to lower diesel prices, but analysts see minimal impact

Big Controversy Upends a Contest About Microscopic Videos